Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its ...

SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...

Supreme Court upholds lower court's decision that SK bioscience's PCV13 components do not fall within scope of Pfizer's patent claims - Anadolu Ajansı ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.

South Korean vaccine maker SK Bioscience has secured a final court victory over US pharma major Pfizer in a long-running patent dispute concerning exports of its 13-valent pneumococcal conjugate ...

SEOUL, May 21 (Yonhap) -- SK bioscience Co., a biotech arm of South Korea's SK Group, said Wednesday it has won a patent ...

Find out who should get a Tdap vaccine – and what other shots all adults should get – before being around a newborn.

WHO, in collaboration with Somali federal and regional governments, to vaccinate 3.1M children under age of 5 during ...

PNEUMONIA having been a reason for the death of more than 12,000 children aged under five, which comes down to more than a child every hour, appears gravely worrying. The disease kills more than one ...